VIMTALABS638.50

Vimta Labs Limited

· Pharma & Health
₹ CrorePeersSUVENTAKEMcap ₹1,416 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Last 12M
31/12/2024
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation23.330.734.2
+ Share-based Payments0.04.11.6
+ Unrealised FX (Gain) / Loss-0.1-0.2-0.2
+ Other Non-cash Items5.54.42.4
Changes in Working Capital
+ Inventories-2.7-5.2-2.1
+ Trade Receivables — Current-9.2-7.3-10.7
+ Other Financial Assets — Current2.5-0.50.2
+ Other Current Assets-3.0-2.41.1
+ Trade Payables — Current-2.32.0-6.1
+ Other Financial Liabilities — Current1.58.00.2
+ Other Current Liabilities5.8-0.1-0.1
+ Provisions — Current-1.12.02.2
Cash from Operating Activities
Profit Before Tax (per I/S)55.765.054.578.6
+ Total Adjustments (incl. Working Capital)20.335.322.6
Cash from Operations (pre-tax)76.0100.377.0
+ Interest Received — Operating-0.9-1.2-1.3
+ Interest Paid — Operating-1.1-2.2-1.7
+ Other Inflows / (Outflows) — Operating-0.5-0.8-1.0
+ Income Taxes Paid16.612.515.5
Cash from Operating Activities59.187.960.9
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)29.847.876.3
+ Acq of Intangible Assets8.92.00.2
+ Disp of Investment Property0.00.22.1
+ Interest Received — Investing0.91.01.5
+ Other Inflows / (Outflows) — Investing-0.0-8.7-3.1
Cash from Investing Activities-37.8-57.3-76.0
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.00.0
+ Proceeds from Borrowings4.50.09.2
+ Repayment of Borrowings15.95.75.2
+ Interest Paid0.80.91.5
+ Dividends Paid4.44.44.4
Cash from Financing Activities-16.6-11.0-1.9
Net Changes in Cash (pre-FX)4.619.7-17.1
Net Changes in Cash4.619.7-17.1
Closing Cash10.830.513.4
Reference Items
EBITDA80.394.986.8111.9
EBITDA Margin %28.8529.8327.2733.30
Free Cash Flow (CFO − Capex)20.338.1-15.7-15.7
Free Cash Flow to Equity32.9-13.0
Free Cash Flow per Basic Share9.1817.20-7.07-7.07
Cash Flow to Net Income1.431.831.48
Cash Paid for Taxes16.612.515.5
Cash Paid for Interest0.80.91.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.